Fundraising Fox
Onchilles Pharma
San Diego, US · Founded 2017 · Delaware corporation · 1 known investors
Find your way into Onchilles Pharma
Sign up to see every warm intro you have to Onchilles Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Onchilles Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Onchilles Pharma is a biopharmaceutical company developing novel therapeutics based on scientific research to address unmet medical needs. The company is led by a team with academic and industry backgrounds in drug development.
Founders & leadership
Onchilles Pharma was founded in 2017 by Lev Becker, Ph.D..
LB
Lev Becker, Ph.D.Founder
MN
Marc NasoffChief Development Officer
CT
Court TurnerNamed on SEC filing
KL
Kevin Li, Ph.D.Named on SEC filing
Investors · 1
Funding
SEC filings, press & company announcements$3.6M disclosed across 1 of 4 rounds · 2020–2025
- Undisclosed amountSeries A1Nov 2025Source ↗
▶$3.6MraisedJul 2020 · 10 investors · BiotechnologyRule 506(b)
▶$3.6MraisedJul 2020 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Court TurnerExecutive Officer, Director
- Kevin Li, Ph.D.Director
- Lev Becker, Ph.D.Director
- Offering amount
- $7.7M
- Amount sold
- $3.6M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
TargetedoncTargeted Oncology is a medical news and education publication for oncologists and cancer care professionals, covering clinical trial data, FDA approvals, treatment guidelines, and expert commentary across cancer types. It delivers conference coverage, podcasts, videos, and short-form content focused on precision oncology and targeted cancer therapies.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as Onchilles Pharma.
In the news
Frequently asked questions
- What does Onchilles Pharma do?
- Onchilles Pharma is a biopharmaceutical company developing novel therapeutics based on scientific research to address unmet medical needs. The company is led by a team with academic and industry backgrounds in drug development.
- Who founded Onchilles Pharma?
- Onchilles Pharma was founded by Lev Becker, Ph.D. in 2017.
- Who are Onchilles Pharma's investors?
- Onchilles Pharma's investors include InVivium Capital.
- How much funding has Onchilles Pharma raised?
- Onchilles Pharma has disclosed $3.6M raised across 1 of its 4 known rounds.
- Where is Onchilles Pharma headquartered?
- Onchilles Pharma is headquartered in San Diego, US.